MERZ NORTH AMERICA, INC RADIESSE(+) INJECTABLE IMPLANT IMPLANT, DERMAL, FOR AESTHETIC USE
|
Back to Search Results |
|
Lot Number 1001130305 |
Device Problem
Adverse Event Without Identified Device or Use Problem (2993)
|
Patient Problem
Obstruction/Occlusion (2422)
|
Event Type
Injury
|
Manufacturer Narrative
|
This case was assessed as reportable to the fda, as the event possible occlusion (pt: vascular occlusion), was deemed to meet the serious criteria of required intervention to prevent permanent damage.
The device history record of radiesse (+) injectable implant could not be reviewed, as the lot number was not reported.
|
|
Event Description
|
This spontaneous report was received from a us nurse and concerns a patient.
The patient was injected with radiesse(+), into the nasolabial folds, cheeks and tear trough region (off label use of device).
After the treatment with radiesse(+), the patient experienced significant swelling and pain when injected into the tear trough.
The outcome of the events was unknown.
Follow-up information was received on 14-apr-2022: this case was upgraded to serious.
The event possible occlusion was added.
The events swelling and pain were deleted, they were considered to be symptoms of the reported possible occlusion.
After the treatment with radiesse(+), the patient experienced significant swelling in the tear trough area and severe pain.
It was further described as a possible occlusion.
The outcome of the event was unknown.
|
|
Search Alerts/Recalls
|
|
|